Craneware plc

Equities

CRW

GB00B2425G68

Software

Delayed London S.E. 05:08:07 2024-07-08 am EDT 5-day change 1st Jan Change
2,370 GBX -0.42% Intraday chart for Craneware plc +2.60% +35.43%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Craneware strengthens Microsoft relationship with landmark deal AN
Craneware Agrees Microsoft AI Alliance for U.S. Healthcare Industry DJ
Craneware to Offer Trisus Platform on Microsoft Azure Marketplace MT
Sainsbury's backs outlook; Ryanair hails record June AN
Craneware Forms Alliance with Microsoft to Further Transform the Business of Healthcare CI
Craneware extends share buyback scheme again by three months AN
Craneware plc's Equity Buyback Plan Extended till July 17, 2024. CI
Craneware profit rises on higher sales; set to meet expectations AN
Jefferies says buy BP; UBS says buy Compass AN
Craneware Posts Higher Fiscal H1 Attributable Profit, Revenue MT
Earnings Flash (CRW.L) CRANEWARE Reports Fiscal H1 Revenue $91.2M MT
Earnings Flash (CRW.L) CRANEWARE Posts Fiscal H1 EPS $0.115 MT
Craneware plc Declares Dividend, Payable on April 15, 2024 CI
Craneware plc Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Craneware in "strong position" after solid six-month performance AN
Craneware Returns to Adjusted EPS Growth in Fiscal H1, Revenue Rises MT
Craneware plc's Equity Buyback Plan Extended till April 17, 2024. CI
FTSE 100 Closes Down 1% as Oil, Mining Stocks Weigh DJ
Craneware enjoys positive start as tracks in line with expectations AN
Craneware extends share buyback programme until January AN
Craneware plc's Equity Buyback Plan Extended till January 17, 2024. CI
Craneware posts an annual surge in revenue but says profit flat AN
Craneware FY23 Attributable Profit Edges Down; Revenue Jumps MT
Earnings Flash (CRW.L) CRANEWARE Posts FY23 Revenue $174M MT
Earnings Flash (CRW.L) CRANEWARE Posts FY23 EPS $0.26 MT
Chart Craneware plc
More charts
Craneware plc is a United Kingdom company that is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company is engaged in automated value cycle solutions, including 340B management, collaborates with United States healthcare providers to plan, execute, and monitor operational and financial performance, so they can deliver quality care to their communities. The Company combines revenue integrity, cost management, 340B performance, and decision enablement into a single, software-as-a-service (SaaS)-based platform. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Referral Verification System, Trisus Medication Formulary, Trisus Medication Financial Management, InSight Audit and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
30.48 USD
Average target price
33.84 USD
Spread / Average Target
+11.01%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRW Stock
  4. News Craneware plc
  5. Craneware to Offer Trisus Platform on Microsoft Azure Marketplace